J Korean Acad Rehabil Med.  2001 Apr;25(2):273-277.

Changes in Compound Muscle Action Potentials according to the Dilution Volume of the Botulinum Toxin Type A

Affiliations
  • 1Department of Rehabilitation Medicine, Seoul National University College of Medicine.
  • 2Department of Dermatology, Seoul National University College of Medicine.

Abstract


OBJECTIVE
To know if changes in compound muscle action potential (CMAP) of human extensor digitorum brevis (EDB) muscle can be enhanced by increase in dilution volume of botulinum toxin type A. METHOD: In 11 healthy volunteers, 2.5 U of botulinum toxin (Botox (R) , Allergen Inc.) in a volume of 0.1 ml normal saline was injected in EDB muscle and the same dose with the dilution volume of 0.5 ml was injected in the opposite side. We measured the pre- and post-injection M-wave amplitude and area of EDB muscle.
RESULTS
The mean post/pre injection amplitude ratio of CMAP were 0.49+/-0.21 with the 0.1 ml of dilution volume and 0.40+/-0.12 with the 0.5 ml of dilution volume. The mean post/pre injection area ratio of CMAP were 0.51 0.18 with the 0.1 ml of dilution volume and 0.44+/-0.15 with the 0.5 ml of dilution volume. There was no significant difference between the two dilution volumes.
CONCLUSION
Five fold increase in dilution volume did not enhance the paralyzing effect of botulinum toxin type A in human EDB muscles.

Keyword

Botulinum toxin; Dilution; Paralysis; Compound muscle action potential

MeSH Terms

Action Potentials*
Botulinum Toxins*
Botulinum Toxins, Type A*
Healthy Volunteers
Humans
Muscles
Paralysis
Botulinum Toxins
Botulinum Toxins, Type A
Full Text Links
  • JKARM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr